computer anti-virus info

Proof-of-concept Articles

Virus > Proof-of-concept > Proof-of-concept Articles

Proof-of-concept

We have 1 page of Proof-of-concept Articles.

1.) M2 Presswire - First malicious code designed for Microsoft Windows CE; Proof-of-concept virus hits the last virus-resistant Microsoft OS.

Over one day ago | Mon Jul 19 0:00:00 PDT 2004

July 19, 2004 -- M2 PRESSWIRE-19 July 2004-BitDefender: First malicious code designed for Microsoft Windows CE; Proof-of-concept virus hits the last virus-resistant...

2.) Market Wire - SciClone Provides Promising Results From Its Phase 2A Clinical Trial Using SCV-07 as a Monotherapy in Patients With Chronic Hepatitis C Infection

Over one day ago | Mon Sep 22 0:00:00 PDT 2008

September 22, 2008 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced promising results from its proof-of-concept phase 2clinical trial using its...

3.) Business Wire - Argos Therapeutics' Arcelis™ Personalized Immunotherapy Platform in HIV Achieves Primary Endpoint in Phase 1 Trial

Over one day ago | Tue Aug 5 0:00:00 PDT 2008

August 5, 2008 -- -Positive Immune Response Data Presented at XVII International AIDS Conference- DURHAM, N.C. -- Argos Therapeutics today announced the presentation...

4.) Market Wire - Lipid Sciences' Autologous Therapeutic HIV Vaccine Study Published in "Experimental Biology and Medicine

Over one day ago | Mon Jun 9 0:00:00 PDT 2008

June 9, 2008 -- Lipid Sciences, Inc. (NASDAQ: LIPD)announced that the results of a proof-of-concept study that demonstrated apositive therapeutic effect with the...

5.) San Diego Business Journal - Ardea HIV drug meets study goals

Over one day ago | Mon Mar 24 0:00:00 PDT 2008

March 24, 2008 -- Arden Biosciences Inc., a San Diego biotechnology firm focused on developing treatments for the AIDS virus HIV, cancer and inflammatory diseases,...

6.) Business Wire - Medivir: Initiation of a Phase IIa Clinical Trial with Investigational Hepatitis C Protease Inhibitor TMC435350

Over one day ago | Wed Nov 21 0:00:00 PST 2007

November 21, 2007 -- STOCKHOLM, Sweden -- Regulatory News: Medivir (STO:MVIRB) announced today that, following the successful completion of a phase I study in both...

7.) Chemistry and Industry - Merck halts HIV drug development

Over one day ago | Mon Oct 8 0:00:00 PDT 2007

October 8, 2007 -- Hopes for a vaccine to prevent HIV infection have taken a blow as Merck has stopped all trials on its experimental product. The vaccine, V520, was...

8.) Software World - Gattman computer virus uses new method of infection

Over one day ago | Sat Jul 1 0:00:00 PDT 2006

July 1, 2006 -- Researchers at the Sydney branch of Sophos have discovered a proof-of-concept virus, called Gattman which works in a novel way. Unlike the majority...

9.) Business Wire - Alnylam Initiates Clinical Program to Evaluate Anti-Viral Activity for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus...

Over one day ago | Tue Nov 28 0:00:00 PST 2006

November 28, 2006 -- First Clinical Protocol to Establish Safe and Reliable Experimental Infection with RSV in Adult Volunteers as Part of Efforts to Advance ALN-RSV01...

10.) Wireless News - Trend Micro Releases SMS Virus Solutionions

Over one day ago | Mon Dec 6 0:00:00 PST 2004

December 6, 2004 -- Wireless News12-06-2004Trend Micro Releases SMS Virus SolutionionsWIRELESS NEWS-6 December 2004-Trend Micro Releases SMS Virus Solutionions (C)2004...